Filing Details

Accession Number:
0001209191-15-065175
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-11 14:56:27
Reporting Period:
2015-08-07
Filing Date:
2015-08-11
Accepted Time:
2015-08-11 14:56:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578408 Nick Leschly C/O Bluebird Bio, Inc.
150 Second Street
Cambridge MA 02141
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-07 6,056 $2.09 252,577 No 4 M Direct
Comon Stock Acquisiton 2015-08-07 28,511 $2.09 281,088 No 4 M Direct
Common Stock Acquisiton 2015-08-07 90,433 $5.50 371,521 No 4 M Direct
Common Stock Disposition 2015-08-07 419 $130.56 371,102 No 4 S Direct
Common Stock Disposition 2015-08-07 1,528 $131.12 369,574 No 4 S Direct
Common Stock Disposition 2015-08-07 12,171 $132.29 357,403 No 4 S Direct
Common Stock Disposition 2015-08-07 2,208 $133.08 355,195 No 4 S Direct
Common Stock Disposition 2015-08-07 1,766 $134.24 353,429 No 4 S Direct
Common Stock Disposition 2015-08-07 17,832 $135.51 335,597 No 4 S Direct
Common Stock Disposition 2015-08-07 19,365 $136.33 316,232 No 4 S Direct
Common Stock Disposition 2015-08-07 15,256 $140.36 300,976 No 4 S Direct
Common Stock Disposition 2015-08-07 15,815 $141.32 285,161 No 4 S Direct
Common Stock Disposition 2015-08-07 7,293 $142.35 277,868 No 4 S Direct
Common Stock Disposition 2015-08-07 13,158 $143.35 264,710 No 4 S Direct
Common Stock Disposition 2015-08-07 6,570 $144.40 258,140 No 4 S Direct
Common Stock Disposition 2015-08-07 4,912 $145.36 253,228 No 4 S Direct
Common Stock Disposition 2015-08-07 2,063 $146.81 251,165 No 4 S Direct
Common Stock Disposition 2015-08-07 1,262 $148.30 249,903 No 4 S Direct
Common Stock Disposition 2015-08-07 1,185 $149.29 248,718 No 4 S Direct
Common Stock Disposition 2015-08-07 1,019 $150.38 247,699 No 4 S Direct
Common Stock Disposition 2015-08-07 862 $151.67 246,837 No 4 S Direct
Common Stock Disposition 2015-08-07 79 $153.66 246,758 No 4 S Direct
Common Stock Disposition 2015-08-07 237 $154.59 246,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-08-07 6,056 $0.00 6,056 $2.09
Common Stock Stock Option (right to buy) Disposition 2015-08-07 28,511 $0.00 28,511 $2.09
Common Stock Stock Option (right to buy) Disposition 2015-08-07 90,433 $0.00 90,433 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,391 2021-07-13 No 4 M Direct
38,605 2022-06-04 No 4 M Direct
390,269 2023-01-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,504 Indirect Nick Leschly 2001 Trust
Footnotes
  1. Includes 272 shares acquired under bluebird bio employee stock purchase plan on July 31, 2015.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015.
  3. The range of prices for the transaction reported on this line was $130.54 to $130.58. The average weighted price was $130.56. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The range of prices for the transaction reported on this line was $130.72 to $131.61. The average weighted price was $131.12. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The range of prices for the transaction reported on this line was $131.85 to $132.64. The average weighted price was $132.29. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. The range of prices for the transaction reported on this line was $132.66 to $133.65. The average weighted price was $133.08. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. The range of prices for the transaction reported on this line was $133.74 to $134.74. The average weighted price was $134.24. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. The range of prices for the transaction reported on this line was $134.95 to $135.91. The average weighted price was $135.51. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. The range of prices for the transaction reported on this line was $135.92 to $136.92. The average weighted price was $136.33. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  10. The range of prices for the transaction reported on this line was $140.00 to $140.79. The average weighted price was $140.36. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  11. The range of prices for the transaction reported on this line was $140.82 to $141.82. The average weighted price was $141.32. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  12. The range of prices for the transaction reported on this line was $141.87 to $142.87. The average weighted price was $142.35. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  13. The range of prices for the transaction reported on this line was $142.90 to $143.89. The average weighted price was $143.35. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  14. The range of prices for the transaction reported on this line was $143.91 to $144.90. The average weighted price was $144.40. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  15. The range of prices for the transaction reported on this line was $145.00 to $146.00. The average weighted price was $145.36. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  16. The range of prices for the transaction reported on this line was $146.16 to $147.11. The average weighted price was $146.81. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  17. The range of prices for the transaction reported on this line was $147.81 to $148.59. The average weighted price was $148.30. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  18. The range of prices for the transaction reported on this line was $149.04 to $149.61. The average weighted price was $149.29. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  19. The range of prices for the transaction reported on this line was $150.00 to $151.00. The average weighted price was $150.38. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  20. The range of prices for the transaction reported on this line was $151.01 to $152.01. The average weighted price was $151.67. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  21. The range of prices for the transaction reported on this line was $154.32 to $154.75. The average weighted price was $154.59. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  22. This option vests over a four-year period, at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter
  23. This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 1, 2013 and in 36 equal monthly installments thereafter.
  24. This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.